Published in:
Open Access 01-02-2019 | Correction
Correction to: Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons
Published in: Diabetes Therapy | Issue 1/2019
Login to get accessExcerpt
In the original publication, Figure 3 was incorrectly published. The authors have updated figure 3 and the corrected Fig. 3 is given below.
Fig. 3
Plots presenting indirect comparisons of empagliflozin versus other glucose-lowering drugs
× ![]()
…